Natrelle 133 Series Tissue Expanders Product Usage: Natrelle 133 Series Tissue Expander is in...
FDA Device Recall #Z-2103-2015 — Class II — June 18, 2015
Recall Summary
| Recall Number | Z-2103-2015 |
| Classification | Class II — Moderate risk |
| Date Initiated | June 18, 2015 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Allergan Inc |
| Location | Irvine, CA |
| Product Type | Devices |
| Quantity | 167 units total (114 units in US) |
Product Description
Natrelle 133 Series Tissue Expanders Product Usage: Natrelle 133 Series Tissue Expander is intended for temporary subcutaneous implantation and require periodic, incremental inflation with sterile saline for injection until the desired amount of tissue is developed.
Reason for Recall
Allergan is recalling the NATRELLE 133 and CUI Series Tissue Expanders because the product shipped was beyond the 47 month shelf life.
Distribution Pattern
US in the state of Canada
Lot / Code Information
Serial No. (Lot No.) 11250691 (1030868), 11514564 (1107468), 11560447 (1120606), 14410441 (1745182), 14460177 (1752996), 14651643 (1782042), 14645258 (1781272), 14418851 (1747035), 14663483 (1784601), 14768174 (1800575), 11650852 (1146235), 11759596 (1175538), 11783801 (1181003), PX1195 (583159), VB9805 (1-116051), PG1537 (567007), PH8804 (569489), PK3108 (570078), PK3369 (570134), PK3381 (570134), PK6626 (570491), PK8403 (570651), PL0978 (570658), PL8893 (571285), PM0276 (571744), PM0279 (571744), PM1034 (571785), PM1035 (571785), PR2461 (575450), PU9968 (579552), PW3583 (581746), PY7600 (585517), QA8130 (592961), QD5894 (619680), NX6700 (559633), QE7679 (620372), 11267520 (1034755), QF7608 (620772), QF7606 (620772), QF9587 (621060), QJ6913 (622768), QP0282 (624977), NW1978 (558962), UM5622 (612529A), PK3255 (569968), PK3423 (570136), PK7369 (570539), PP0932 (574053), PR2462 (575450), QF9588 (621060), 11372224 (1076904), 11397846 (1080914), PT8307 (577871), PT8312 (577871), PU3940 (578909), PV9233 (581160), PV9228 (581160), PW8262 (582676), PW8276 (582676), PW3563 (581746), UM3161 (612983), UP7183 (614339), UP7173 (614339), QF7615 (620772), QG7571 (621426), 11237155 (1029108), NX9778 (559999), PN4372 (573203), PA0253 (561356), PW3861 (581836), PW8259 (582676), UN3074 (613518), PG1546 (567007), UW7921 (617765), 11200803 (1001347), 11201052 (1001668), 11206048 (1004514), 11206049 (1004514), 11206681 (1006447), 11250680 (1030868), 11250702 (1030871), 11514565 (1107468), 11250734 (1030876), 11263982 (1034109), 11269159 (1035181), 11269154 (1035181), 11284363 (1038784), 11307159 (1046470), 11348914 (1067365), 11346491 (1068038), 11367799 (1076435), 11406083 (1088212), 11406084 (1088212), 11406085 (1088212), 11424452 (1091673), 11637421 (1129216), 11718948 (1164435), 11729830 (1165720), 11739519 (1171269), 11759602 (1175538), 12477973 (1383846), 12477975 (1383846), 12495792 (1387445), 12567989 (1402594), 13098492 (1513910), 13098502 (1513910), 11247636 (1030431), 11254038 (1031312), 11368096 (1075819), 11458035 (1097974), 11458039 (1097974), 11458341 (1098680), 11478944 (1102774), 11347486 (1067367).
Other Recalls from Allergan Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2104-2015 | Class II | Natrelle CUI Series Tissue Expanders. Produc... | Jun 18, 2015 |
| Z-1988-2015 | Class II | Natrelle Re-sterilizable Breast Implant Sizer, ... | Jun 8, 2015 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.